DAB2IP 抗体 (AA 782-1038)
-
- 抗原 See all DAB2IP 抗体
- DAB2IP (DAB2 Interacting Protein (DAB2IP))
-
抗原表位
- AA 782-1038
-
适用
- 人, 小鼠
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This DAB2IP antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 纯化方法
- This antibody is purified through a protein G column, followed by dialysis against PBS.
- 免疫原
- This DAB2IP antibody is generated from a mouse immunized with a recombinant protein between 782-1038 amino acids from human DAB2IP.
- 克隆位点
- 1626CT702-263-21
- 亚型
- IgG2a kappa
- Top Product
- Discover our top product DAB2IP Primary Antibody
-
anti-DAB2 Interacting Protein (DAB2IP) (AA 551-650) antibody
DAB2IP 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 8C10 unconjugated
anti-DAB2 Interacting Protein (DAB2IP) antibodyDAB2IP 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-DAB2 Interacting Protein (DAB2IP) antibodyDAB2IP 适用: 人, 小鼠 WB 宿主: 小鼠 Monoclonal 6C1 unconjugated
anti-DAB2 Interacting Protein (DAB2IP) (AA 85-100) antibodyDAB2IP 适用: 人 ELISA, IF 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- WB: 1:1000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 有效期
- 6 months
-
- 抗原
- DAB2IP (DAB2 Interacting Protein (DAB2IP))
- 别名
- DAB2IP (DAB2IP 产品)
- 别名
- dab2ip antibody, wu:fc08b07 antibody, wu:fk62h05 antibody, AF9Q34 antibody, AIP-1 antibody, AIP1 antibody, DIP1/2 antibody, 2310011D08Rik antibody, AI480459 antibody, Aip1 antibody, mKIAA1743 antibody, disabled homolog 2-interacting protein antibody, DAB2 interacting protein antibody, DAB2 interacting protein b antibody, disabled 2 interacting protein antibody, LOC100071680 antibody, DAB2IP antibody, dab2ipb antibody, dab2ip antibody, Dab2ip antibody
- 背景
- Functions as a scaffold protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Involved in several processes such as innate immune response, inflammation and cell growth inhibition, apoptosis, cell survival, angiogenesis, cell migration and maturation. Plays also a role in cell cycle checkpoint control, reduces G1 phase cyclin levels resulting in G0/G1 cell cycle arrest. Mediates signal transduction by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF), interferon (IFN) or lipopolysaccharide (LPS). Modulates the balance between phosphatidylinositol 3-kinase (PI3K)-AKT-mediated cell survival and apoptosis stimulated kinase (MAP3K5)-JNK signaling pathways, sequesters both AKT1 and MAP3K5 and counterbalances the activity of each kinase by modulating their phosphorylation status in response to proinflammatory stimuli. Acts as a regulator of the endoplasmic reticulum (ER) unfolded protein response (UPR) pathway, specifically involved in transduction of the ER stress-response to the JNK cascade through ERN1. Mediates TNF-alpha-induced apoptosis activation by facilitating dissociation of inhibitor 14-3-3 from MAP3K5, recruits the PP2A phosphatase complex which dephosphorylates MAP3K5 on 'Ser-966', leading to the dissociation of 13-3-3 proteins and activation of the MAP3K5-JNK signaling pathway in endothelial cells. Mediates also TNF/TRAF2-induced MAP3K5-JNK activation, while it inhibits CHUK-NF-kappa-B signaling. Acts a negative regulator in the IFN-gamma-mediated JAK-STAT signaling cascade by inhibiting smooth muscle cell (VSMCs) proliferation and intimal expansion, and thus, prevents graft arteriosclerosis (GA). Acts as a GTPase-activating protein (GAP) for the ADP ribosylation factor 6 (ARF6) and Ras. Promotes hydrolysis of the ARF6-bound GTP and thus, negatively regulates phosphatidylinositol 4,5- bisphosphate (PIP2)-dependent TLR4-TIRAP-MyD88 and NF-kappa-B signaling pathways in endothelial cells in response to lipopolysaccharides (LPS). Binds specifically to phosphatidylinositol 4-phosphate (PtdIns4P) and phosphatidylinositol 3-phosphate (PtdIns3P). In response to vascular endothelial growth factor (VEGFA), acts as a negative regulator of the VEGFR2-PI3K-mediated angiogenic signaling pathway by inhibiting endothelial cell migration and tube formation. In the developing brain, promotes both the transition from the multipolar to the bipolar stage and the radial migration of cortical neurons from the ventricular zone toward the superficial layer of the neocortex in a glial-dependent locomotion process. Probable downstream effector of the Reelin signaling pathway, promotes Purkinje cell (PC) dendrites development and formation of cerebellar synapses. Functions also as a tumor suppressor protein in prostate cancer progression, prevents cell proliferation and epithelial-to-mesenchymal transition (EMT) through activation of the glycogen synthase kinase-3 beta (GSK3B)-induced beta-catenin and inhibition of PI3K-AKT and Ras-MAPK survival downstream signaling cascades, respectively.
- 分子量
- 131625
- UniProt
- Q5VWQ8
- 途径
- EGFR Signaling Pathway, Cellular Response to Molecule of Bacterial Origin, Tube Formation
-
